Skip to content

Using Neuroscience to Optimize Digital Health Interventions Across Adulthood

Using Neuroscience to Optimize Digital Health Interventions Across Adulthood

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03744052
Enrollment
44
Registered
2018-11-16
Start date
2019-01-17
Completion date
2020-05-18
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The goal of this study is to investigate the extent to which brain imaging data predict health behavior change, compared to participant self-reports.

Interventions

Messages regarding physical activity will be texted to participants.

Sponsors

Duke University: Bass Connections
CollaboratorUNKNOWN
National Institutes of Health (NIH)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults ages 30-80 who read/understand English, 50% male and 50% female, and a maximum of 50% will be white.

Exclusion criteria

* Pregnancy * History of head injury * Mental illness diagnosis * Psychoactive medication * Psychiatric or neurological history * Claustrophobia * Ferrous metal implanted within the body (those with fMRI-compatible implanted devices will not be excluded, but the eligibility of their devices will be first verified.) * Asthma, injuries, or other health conditions which inhibit daily physical activity * Subjects must not already meet the recommended amount of physical activity of moderate-intensity physical activity for 150 minutes a week or 75 minutes at vigorous-intensity a week. * Duke students are excluded from this study

Design outcomes

Primary

MeasureTime frame
Change in Physical Activity as measures by FitBitBaseline (14 days after the 1st visit), End of study (80 days after the MR visit)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026